Page 4 - Eye Services News Today

VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four WeeksVEVYE® is the Only Water-Free Ophthalmic Product with Convenient Twice-Daily (BID) DosingNASHVILLE, Tenn. & HEIDELBERG, Germany--(BUSINESS WIRE)...

18.07.2023 - Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, and Novaliq GmbH, a German biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced an agreement under which Harrow will acquire the ... Seite 1

Tripoli-based Libyan Prime Minister Abd Alhamid Aldabaiba, accompanied by the head of the Audit Bureau, Khaled Shakshak, and the Deputy

The three-floor facility will bring together the outpatient and surgical eye treatments that are currently provided at Derriford Hospital

Company Insights for the Health Practitioners Industry | Impact of Trends and Challenges on Companies, Risk of Doing Business, Top Geographical Competitors, Key Executive Details | BizVibe News provided by Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/ -- BizVibe has identified the digitization of health records as a major trend for the health practitioners industry. The digitization of health records is helping health practitioners reduce time spent with each pati...

CANANDAIGUA - For Leanne Bossert, the denials began in December 2020. "I was shocked, I was scared, and I went away from my other kids and I cried," said Bossert, 38. "I didn’t even know it was something that would happen." Her health insurance company, Excellus BlueCross BlueShield, denied coverage of proton radiation therapy treatment for her two brain tumors. As she admitted in a phone interview, the initial denial was jarring, as she thought "the most difficult part of this scenario wo...

CANANDAIGUA, NY — For Leanne Bossert, the denials began in December 2020. "I was shocked, I was scared, and I went away from my other kids and I cried," said Bossert, 38. "I didn’t even know it was something that would happen." Her health insurance company, Excellus BlueCross BlueShield, denied coverage of proton radiation therapy treatment for her two brain tumors. As she admitted in a phone interview, the initial denial was jarring, as she thought "the most difficult part of this scenar...